RecruitingNCT03919305
Cerebral Venous Thrombosis Cohort Study in China Mainland
Sponsor
Capital Medical University
Enrollment
3,000 participants
Start Date
Jan 1, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.
Eligibility
Inclusion Criteria1
- Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance venography (MRV), computed tomography venography (CTV) or high-resolution magnetic resonance imaging (HR-MRI).
Exclusion Criteria1
- None of the patient, trustee or immediate family members signed the informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03919305
Related Trials
The Norwegian Cerebral Venous Thrombosis Study
NCT050211981 location
Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
NCT065838891 location
Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
NCT065514151 location
Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
NCT065514021 location